What Is RxSight, Inc. (RXST) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, RxSight, Inc.'s intrinsic value is estimated at $4.55, presenting a divided outlook at the current price of $4.92. With an average implied return of -7.5% across a split 4–5 (bull–bear) consensus, the model spread of +131.9% underscores analytical uncertainty. Notably, FTNN sees the most upside at +61.8% (fair value: $7.96), while ML-RIV is the most conservative at -70.1% ($1.47). The spread between these extremes — +131.9% — reveals how different analytical frameworks can reach starkly different conclusions.
What Do the Models Say About RXST?
11 of 13 models are currently active for RXST. Of these, 4 models suggest upside while 7 models suggest overvaluation. The Bayesian DCF estimates RXST's intrinsic value at $1.55, implying -68.5% downside from the current price. See which stocks rank higher →
How Does RXST Rank in Ophthalmic Goods?
Among 7 Ophthalmic Goods stocks, RXST ranks #5 by Quality of Company score. CirclFi's QOC score of 6.5/10 evaluates 32 fundamental signals. A score of 6.5 indicates above-average quality.
RxSight, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is RXST a Value Trap?
CirclFi's Value Trap algorithm assigns RXST a score of 24/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
11 of 13 models are active for RxSight, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, RxSight, Inc.'s fundamental quality profile registers 6.5/10. This respectable score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +131.9% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every RXST valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across RXST's 11 active models, average confidence is 28%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad